A number of other analysts have also commented on the stock. Canaccord Genuity cut their price objective on shares of Jamieson Wellness from C$28.00 to C$26.00 in a research report on Wednesday. National Bank Financial cut their price objective on shares of Jamieson Wellness from C$29.00 to C$27.00 and set an outperform rating on the stock in a research report on Wednesday. Finally, BMO Capital Markets lowered shares of Jamieson Wellness from an outperform rating to a market perform rating and cut their price objective for the stock from C$28.00 to C$24.00 in a research report on Wednesday. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of Buy and a consensus price target of C$26.60.
Shares of JWEL stock opened at C$18.75 on Wednesday. The company has a quick ratio of 0.86, a current ratio of 1.83 and a debt-to-equity ratio of 77.16. Jamieson Wellness has a 12 month low of C$17.15 and a 12 month high of C$27.88.
Jamieson Wellness Company Profile
Jamieson Wellness Inc develops, manufactures, distributes, sells, and markets natural health products worldwide. The company operates in two segments, Jamieson Brands and Strategic Partners. The company offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and LVHS brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands.
Read More: Compound Annual Growth Rate (CAGR)
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.